Abstract
AbstractStudy Finds No Significant Benefits of Long‐Acting Injectable RisperidoneGene Variants Predict Ondansetron Efficacy in Treating Heavy‐Drinking AlcoholicsOlanzapine and Ethinylestradiol‐Containing ContraceptivesAntipsychotic Nonadherence and Relapse Risk in Early‐Phase SchizophreniaPharmacogenetics and the Treatment of AlcoholismLong‐Acting Risperidone: Commentary by J.P. Lindenmayer, M.D.Risks of Psychotropic Medication Use in Elderly Nursing Home ResidentsAntidepressant Use in Patients with Depression and Chronic Physical IllnessQuetiapine Gradual Dose Increase Associated with Worsening ManiaNew ApprovalsSafety Labeling Changes
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
